Osiris Therapeutics (OSIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,747 | -1,678 | -5,537 | -1,272 | -9,902 |
| Depreciation Amortization | 552 | 177 | 348 | 177 | 577 |
| Income taxes - deferred | N/A | 2,188 | N/A | N/A | 982 |
| Accounts receivable | -2,163 | -1,401 | -665 | -269 | -520 |
| Other Working Capital | -80 | -1,187 | -3,970 | -3,315 | -467 |
| Other Operating Activity | -5,833 | -8,198 | 1,352 | 654 | -11,106 |
| Operating Cash Flow | $-13,271 | $-10,099 | $-8,472 | $-4,025 | $-20,436 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 13,452 | 9,440 | 7,952 | 3,970 | 20,585 |
| PPE Investments | -128 | -57 | -38 | -20 | -81 |
| Investing Cash Flow | $13,324 | $9,383 | $7,914 | $3,950 | $20,504 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -22 | -11 | N/A | 0 | N/A |
| Common Stock Issued | 87 | 48 | 6 | N/A | 22 |
| Other Financing Activity | 75 | 74 | 0 | 0 | 129 |
| Financing Cash Flow | $140 | $111 | $6 | $N/A | $151 |
| Beginning Cash Position | 1,661 | 1,661 | 1,661 | 1,661 | 1,442 |
| End Cash Position | 1,854 | 1,056 | 1,109 | 1,586 | 1,661 |
| Net Cash Flow | $193 | $-605 | $-552 | $-75 | $219 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,271 | -10,099 | -8,472 | -4,025 | -20,436 |
| Capital Expenditure | -128 | -57 | -38 | -20 | -81 |
| Free Cash Flow | -13,399 | -10,156 | -8,510 | -4,045 | -20,517 |